Provided herein are compositions and methods for the treatment of eosinophilic inflammatory diseases of the mucosal surfaces using proton pump inhibitors. In particular, administration of inhibitors of H,K-ATPase (ATP12A) provides treatment for eosinophilic inflammatory diseases.

The present invention relates to methods and compositions containing oligonucleotides suitable for administration to humans and other mammals.